New insider activity at Merit Medical Systems ( (MMSI) ) has taken place on August 25, 2025.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Director Lynne Ward has recently sold 3,000 shares of Merit Medical Systems stock, amounting to a total transaction value of $265,680.
Recent Updates on MMSI stock
Merit Medical Systems has recently seen a series of developments impacting its stock price. The company announced the enrollment of the first patient in the WRAP North America registry and the US commercial release of the Prelude Wave Hydrophilic Sheath Introducer, both of which are expected to enhance its product offerings. The recent earnings call highlighted robust revenue growth, improved operating margins, and strategic acquisitions, although challenges such as reimbursement delays for WRAPSODY CIE and reduced sales in China were noted. These factors contributed to a mixed outlook, with Baird and Piper Sandler lowering their price targets due to concerns over reimbursement delays and macroeconomic challenges in China, despite strong Q2 performance and strategic growth initiatives. The company’s guidance for 2025 remains optimistic, projecting revenue growth and improved EPS, driven by operational efficiencies and lower-than-expected tariff impacts.
Spark’s Take on MMSI Stock
According to Spark, TipRanks’ AI Analyst, MMSI is a Outperform.
Merit Medical Systems demonstrates strong financial performance and positive earnings call sentiment, which are the most significant factors supporting its stock score. However, technical indicators suggest potential bearish momentum, and the stock’s high P/E ratio indicates overvaluation, which tempers the overall score.
To see Spark’s full report on MMSI stock, click here.
More about Merit Medical Systems
YTD Price Performance: -6.89%
Average Trading Volume: 611,214
Technical Sentiment Signal: Hold
Current Market Cap: $5.3B